Community Health Systems, Inc. (CYH) 10-Year Financial Performance & Capital Metrics

CYH •

HealthcareHealthcare FacilitiesHospitals and inpatient facilities

AboutCommunity Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, retail clinics, and direct-to-consumer virtual health visits. As of December 31, 2021, it owned or leased 83 hospitals, including 81 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals with an aggregate of 13,289 licensed beds. The company was founded in 1985 and is headquartered in Franklin, Tennessee.Show more

Revenue $12.48B -1.2%
EBITDA $1.91B +101.9%
Net Income $509M +198.6%
EPS (Diluted) 3.77 +196.7%
Gross Margin 56.65% +35.8%
EBITDA Margin 15.33% +104.3%
Operating Margin 11.92% +177.8%
Net Margin 4.08% +199.8%
ROE -
ROIC 20.99% +469.4%
Debt/Equity -
Interest Coverage 1.71 +172.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 8/9

✗Weaknesses

✗Thin 5Y average net margin of 0.2%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-4.33%

5Y1.15%

3Y0.74%

TTM-1.19%

Profit (Net Income) CAGR

10Y12.41%

5Y-0.08%

3Y122.84%

TTM198.84%

EPS CAGR

10Y10.65%

5Y-2.95%

3Y120.85%

TTM196.76%

ROCE

10Y Avg4.24%

5Y Avg8.52%

3Y Avg8.45%

Latest13.11%

Peer Comparison

Hospitals and inpatient facilities

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
UHTUniversal Health Realty Income Trust	605.21M	43.62	34.35	-100%	11.84%	11.56%	8.11%
HCAHCA Healthcare, Inc.	118.45B	529.70	18.66	7.08%	8.97%		6.49%
THCTenet Healthcare Corporation	21.04B	239.39	15.45	3.12%	6.6%	15.68%	12.03%	1.47
AUNAAuna S.A.	160.71M	5.34	10.99	14.47%	4.33%	10.05%	100%	2.32
UHSUniversal Health Services, Inc.	2.58M	206.10	8.92	9.71%	8.57%	20.09%	100%	0.70
ARDTArdent Health Partners, LLC	1.34B	9.39	5.94	10.29%	3.24%	12.57%	9.51%	1.50
CYHCommunity Health Systems, Inc.	484.81M	3.46	0.92	-1.18%	4.08%		42.9%
ACHCAcadia Healthcare Company, Inc.	2.12B	23.44	-1.93	5.04%	-33.29%	-51.52%		1.23

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	18.44B	15.35B	14.15B	13.21B	11.79B	12.37B	12.21B	12.49B	12.63B	12.48B
Revenue Growth %	-5.14%	-16.73%	-7.8%	-6.68%	-10.76%	4.91%	-1.27%	2.28%	1.15%	-1.18%
Cost of Goods Sold+	11.63B	10.05B	8.74B	8.1B	7.37B	7.28B	7.3B	7.41B	7.36B	5.41B
COGS % of Revenue	63.1%	65.45%	61.74%	61.3%	62.55%	58.89%	59.82%	59.31%	58.29%	43.35%
Gross Profit+	6.8B	5.3B	5.42B	5.11B	4.42B	5.08B	4.91B	5.08B	5.27B	7.07B
Gross Margin %	36.9%	34.55%	38.26%	38.7%	37.45%	41.11%	40.18%	40.69%	41.71%	56.65%
Gross Profit Growth %	-8.04%	-22.02%	2.09%	-5.61%	-13.63%	15.15%	-3.5%	3.59%	3.7%	34.21%
Operating Expenses+	7.66B	7.18B	5.21B	4.46B	3.29B	3.68B	4.08B	4.13B	4.73B	11B
OpEx % of Revenue	41.56%	46.79%	36.79%	33.78%	27.9%	29.77%	33.45%	33.03%	37.42%	88.08%
Selling, General & Admin	450M	394M	337M	321M	327M	308M	317M	319M	299M	0
SG&A % of Revenue	2.44%	2.57%	2.38%	2.43%	2.77%	2.49%	2.6%	2.55%	2.37%	-
Research & Development	0	0	0	0	0	108M	85M	80M	0	0
R&D % of Revenue	-	-	-	-	-	0.87%	0.7%	0.64%	-	-
Other Operating Expenses	7.21B	6.79B	4.87B	4.14B	2.96B	3.27B	3.68B	3.73B	4.43B	11B
Operating Income+	-860M	-1.88B	208M	650M	1.13B	1.4B	821M	957M	542M	1.49B
Operating Margin %	-4.66%	-12.23%	1.47%	4.92%	9.55%	11.34%	6.72%	7.66%	4.29%	11.92%
Operating Income Growth %	-164.32%	-118.37%	111.08%	212.5%	73.23%	24.51%	-41.44%	16.57%	-43.36%	174.54%
EBITDA+	39M	-1.2B	768M	1.14B	1.56B	1.83B	1.27B	1.38B	948M	1.91B
EBITDA Margin %	0.21%	-7.78%	5.43%	8.61%	13.24%	14.83%	10.4%	11.06%	7.5%	15.33%
EBITDA Growth %	-98.3%	-3164.1%	164.27%	48.05%	37.29%	17.49%	-30.75%	8.82%	-31.4%	101.9%
D&A (Non-Cash Add-back)	899M	683M	560M	487M	435M	432M	449M	425M	406M	426M
EBIT	1.08B	216M	892M	902M	573M	1.28B	719M	870M	843M	0
Net Interest Income+	-962M	-931M	-976M	-1.04B	-1.03B	-885M	-858M	-830M	-860M	0
Interest Income	0	11M	0	0	0	0	0	2M	3M	0
Interest Expense	962M	942M	976M	1.04B	1.03B	885M	858M	832M	863M	870M
Other Income/Expense	-855M	-955M	-923M	0	-704M	-903M	-472M	-750M	-825M	-764M
Pretax Income+	-1.72B	-2.83B	-715M	-430M	422M	499M	349M	207M	-283M	724M
Pretax Margin %	-9.3%	-18.45%	-5.05%	-3.26%	3.58%	4.03%	2.86%	1.66%	-2.24%	5.8%
Income Tax+	-104M	-449M	-11M	160M	-185M	131M	170M	191M	79M	48M
Effective Tax Rate %	100.35%	86.8%	110.21%	137.21%	121.09%	46.09%	13.18%	-64.25%	182.33%	70.3%
Net Income+	-1.72B	-2.46B	-788M	-590M	511M	230M	46M	-133M	-516M	509M
Net Margin %	-9.33%	-16.02%	-5.57%	-4.47%	4.33%	1.86%	0.38%	-1.06%	-4.08%	4.08%
Net Income Growth %	-1189.24%	-42.88%	67.95%	25.13%	186.61%	-54.99%	-80%	-389.13%	-287.97%	198.64%
Net Income (Continuing)	-1.61B	-2.38B	-704M	-590M	607M	368M	179M	16M	-362M	509M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	667M	602M	576M	579M	571M	562M	633M	568M	597M	322M
EPS (Diluted)+	-15.54	-22.00	-6.99	-5.19	4.38	1.76	0.35	-1.02	-3.90	3.77
EPS Growth %	-1234.31%	-41.57%	68.23%	25.75%	184.39%	-59.82%	-80.11%	-391.43%	-282.35%	196.67%
EPS (Basic)	-15.55	-22.00	-6.99	-5.19	4.42	1.82	0.36	-1.02	-3.90	3.81
Diluted Shares Outstanding	110.73M	111.77M	112.73M	113.74M	116.54M	130.6M	130.06M	130.45M	132.1M	135M
Basic Shares Outstanding	110.71M	111.77M	112.73M	113.74M	115.49M	126.75M	128.81M	130.39M	132.1M	134M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	4.67B	4.07B	3.55B	3.43B	4.51B	3.48B	3.08B	3.21B	3.3B	3.23B
Cash & Short-Term Investments	238M	563M	196M	216M	1.68B	507M	118M	38M	37M	260M
Cash Only	238M	563M	196M	216M	1.68B	507M	118M	38M	37M	260M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	3.36B	2.54B	2.51B	2.4B	2.06B	2.18B	2.14B	2.36B	2.45B	2.08B
Days Sales Outstanding	66.55	60.31	64.65	66.18	63.87	64.22	63.88	69	70.69	60.72
Inventory	480M	444M	402M	354M	335M	355M	353M	328M	331M	0
Days Inventory Outstanding	15.06	16.13	16.79	15.96	16.58	17.79	17.64	16.16	16.41	-
Other Current Assets	382M	309M	245M	221M	202M	155M	138M	145M	197M	897M
Total Non-Current Assets+	17.28B	13.38B	12.31B	12.18B	11.5B	11.74B	11.59B	11.25B	10.75B	9.97B
Property, Plant & Equipment	8.15B	7.05B	6.14B	6.21B	5.96B	6.22B	6.1B	5.87B	5.4B	8.91B
Fixed Asset Turnover	2.26x	2.18x	2.31x	2.13x	1.98x	1.99x	2.00x	2.13x	2.34x	1.40x
Goodwill	6.52B	4.72B	4.56B	4.33B	4.22B	4.22B	4.17B	3.96B	3.79B	3.32B
Intangible Assets	674M	505M	423M	385M	305M	270M	224M	205M	172M	0
Long-Term Investments	177M	171M	269M	283M	190M	129M	155M	170M	152M	0
Other Non-Current Assets	1.76B	869M	851M	933M	759M	846M	890M	1.01B	1.23B	-2.31B
Total Assets+	21.94B	17.45B	15.86B	15.61B	16.01B	15.22B	14.67B	14.46B	14.05B	13.2B
Asset Turnover	0.84x	0.88x	0.89x	0.85x	0.74x	0.81x	0.83x	0.86x	0.90x	0.95x
Asset Growth %	-18.31%	-20.48%	-9.12%	-1.58%	2.54%	-4.93%	-3.6%	-1.46%	-2.77%	-6.05%
Total Current Liabilities+	2.89B	2.36B	2.39B	2.28B	2.81B	2.36B	2.19B	2.14B	2.35B	2.21B
Accounts Payable	880M	801M	772M	718M	683M	725M	686M	811M	784M	842M
Days Payables Outstanding	27.61	29.1	32.24	32.36	33.81	36.33	34.28	39.96	38.86	56.79
Short-Term Debt	455M	33M	204M	156M	265M	178M	169M	145M	135M	126M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	821M	837M	789M	814M	1.23B	806M	694M	615M	830M	2.08B
Current Ratio	1.62x	1.73x	1.48x	1.50x	1.60x	1.47x	1.41x	1.50x	1.41x	1.46x
Quick Ratio	1.45x	1.54x	1.32x	1.35x	1.48x	1.32x	1.25x	1.34x	1.27x	1.46x
Cash Conversion Cycle	54.01	47.35	49.19	49.77	46.65	45.68	47.24	45.2	48.24	-
Total Non-Current Liabilities+	16.77B	15.26B	14.43B	14.97B	14.24B	13.66B	13.22B	13.14B	13.03B	11.83B
Long-Term Debt	14.49B	13.59B	13.17B	13.12B	11.86B	11.72B	11.39B	11.25B	11.24B	537M
Capital Lease Obligations	302M	287M	218M	752M	756M	923M	825M	777M	728M	0
Deferred Tax Liabilities	411M	19M	26M	200M	29M	192M	354M	369M	231M	25M
Other Non-Current Liabilities	1.57B	1.36B	1.01B	894M	1.6B	827M	644M	739M	828M	11.27B
Total Liabilities	19.66B	17.61B	16.82B	17.25B	17.06B	16.03B	15.4B	15.28B	15.37B	14.04B
Total Debt+	15.24B	13.91B	13.6B	14.03B	12.88B	12.82B	12.39B	12.17B	12.1B	663M
Net Debt	15.01B	13.35B	13.4B	13.81B	11.21B	12.31B	12.27B	12.14B	12.06B	403M
Debt / Equity	6.68x	-	-	-	-	-	-	-	-	-
Debt / EBITDA	390.87x	-	17.70x	12.34x	8.25x	6.99x	9.75x	8.81x	12.77x	0.35x
Net Debt / EBITDA	384.77x	-	17.45x	12.15x	7.18x	6.71x	9.66x	8.78x	12.73x	0.21x
Interest Coverage	-0.89x	-1.99x	0.21x	0.62x	1.09x	1.58x	0.96x	1.15x	0.63x	1.71x
Total Equity+	2.28B	-165M	-959M	-1.64B	-1.05B	-810M	-734M	-824M	-1.32B	-515M
Equity Growth %	-51.2%	-107.23%	-481.21%	-70.91%	35.69%	23.15%	9.38%	-12.26%	-59.83%	60.9%
Book Value per Share	20.61	-1.48	-8.51	-14.41	-9.04	-6.20	-5.64	-6.32	-9.97	-3.81
Total Shareholders' Equity	1.61B	-767M	-1.53B	-2.22B	-1.63B	-1.37B	-1.37B	-1.39B	-1.91B	-837M
Common Stock	1M	1M	1M	1M	1M	1M	1M	1M	1M	1M
Retained Earnings	-299M	-2.76B	-3.54B	-4.22B	-3.71B	-3.48B	-3.43B	-3.56B	-4.08B	-3.57B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-62M	-21M	-10M	-9M	-13M	-14M	-21M	-14M	-10M	-9M
Minority Interest	667M	602M	576M	579M	571M	562M	633M	568M	597M	322M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	1.14B	773M	274M	385M	2.18B	-131M	300M	210M	480M	543M
Operating CF Margin %	6.17%	5.03%	1.94%	2.91%	18.47%	-1.06%	2.46%	1.68%	3.8%	4.35%
Operating CF Growth %	23.45%	-32.01%	-64.55%	40.51%	465.71%	-106.01%	329.01%	-30%	128.57%	13.13%
Net Income	-1.71B	-2.45B	-788M	-675M	511M	230M	46M	-133M	-516M	676M
Depreciation & Amortization	1.1B	861M	700M	608M	558M	540M	534M	505M	486M	426M
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	11M
Deferred Taxes	-116M	-454M	-3M	203M	-187M	170M	165M	35M	-116M	-243M
Other Non-Cash Items	3.25B	2.29B	783M	520M	-29M	305M	34M	193M	635M	-327M
Working Capital Changes	-177M	525M	-418M	-271M	1.32B	-1.38B	-479M	-390M	-9M	0
Change in Receivables	-96M	732M	31M	93M	309M	-136M	22M	-193M	-66M	99M
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	0	-157M	-67M	16M	-158M	-50M	137M	0
Cash from Investing+	-608M	1.07B	-273M	-3M	191M	-543M	-251M	-22M	-277M	847M
Capital Expenditures	-867M	-570M	-527M	-438M	-440M	-469M	-415M	-467M	-360M	-335M
CapEx % of Revenue	4.7%	3.71%	3.72%	3.32%	3.73%	3.79%	3.4%	3.74%	2.85%	2.68%
Acquisitions	139M	1.7B	359M	593M	665M	5M	126M	426M	152M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	121M	0	0	1.2B
Cash from Financing+	-1.69B	-1.52B	-368M	-362M	-909M	-495M	-438M	-268M	-204M	-1.17B
Debt Issued (Net)	-1.86B	-1.52B	-1.07B	-322M	-794M	-369M	-305M	-123M	-48M	0
Equity Issued (Net)	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-6M	-5M	-1M	-1M	-1M	-5M	-8M	-4M	-1M	0
Other Financing	174M	5M	701M	-39M	-114M	-121M	-125M	-141M	-155M	-1.17B
Net Change in Cash	54M	325M	-367M	20M	1.46B	-1.17B	-389M	-80M	-1M	223M
Free Cash Flow+	1.49B	203M	-253M	-53M	1.74B	-600M	-115M	-257M	120M	208M
FCF Margin %	8.08%	1.32%	-1.79%	-0.4%	14.74%	-4.85%	-0.94%	-2.06%	0.95%	1.67%
FCF Growth %	1773.03%	-86.37%	-224.63%	79.05%	3379.25%	-134.52%	80.83%	-123.48%	146.69%	73.33%
FCF per Share	13.45	1.82	-2.24	-0.47	14.91	-4.59	-0.88	-1.97	0.91	1.54
FCF Conversion (FCF/Net Income)	-0.66x	-0.31x	-0.35x	-0.65x	4.26x	-0.57x	6.52x	-1.58x	-0.93x	1.07x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-49.47%	-232.31%	-	-	-	-	-	-	-	-
Return on Invested Capital (ROIC)	-3.32%	-9.24%	1.22%	3.96%	7.57%	9.71%	5.34%	6.28%	3.69%	20.99%
Gross Margin	36.9%	34.55%	38.26%	38.7%	37.45%	41.11%	40.18%	40.69%	41.71%	56.65%
Net Margin	-9.33%	-16.02%	-5.57%	-4.47%	4.33%	1.86%	0.38%	-1.06%	-4.08%	4.08%
Debt / Equity	6.68x	-	-	-	-	-	-	-	-	-
Interest Coverage	-0.89x	-1.99x	0.21x	0.62x	1.09x	1.58x	0.96x	1.15x	0.63x	1.71x
FCF Conversion	-0.66x	-0.31x	-0.35x	-0.65x	4.26x	-0.57x	6.52x	-1.58x	-0.93x	1.07x
Revenue Growth	-5.14%	-16.73%	-7.8%	-6.68%	-10.76%	4.91%	-1.27%	2.28%	1.15%	-1.18%

US Stock Screener

...

Community Health Systems, Inc. (CYH) 10-Year Financial Performance & Capital Metrics

CYH •

HealthcareHealthcare FacilitiesHospitals and inpatient facilities

Revenue $12.48B -1.2%
EBITDA $1.91B +101.9%
Net Income $509M +198.6%
EPS (Diluted) 3.77 +196.7%
Gross Margin 56.65% +35.8%
EBITDA Margin 15.33% +104.3%
Operating Margin 11.92% +177.8%
Net Margin 4.08% +199.8%
ROE -
ROIC 20.99% +469.4%
Debt/Equity -
Interest Coverage 1.71 +172.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 8/9

✗Weaknesses

✗Thin 5Y average net margin of 0.2%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-4.33%

5Y1.15%

3Y0.74%

TTM-1.19%

Profit (Net Income) CAGR

10Y12.41%

5Y-0.08%

3Y122.84%

TTM198.84%

EPS CAGR

10Y10.65%

5Y-2.95%

3Y120.85%

TTM196.76%

ROCE

10Y Avg4.24%

5Y Avg8.52%

3Y Avg8.45%

Latest13.11%

Peer Comparison

Hospitals and inpatient facilities

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
UHTUniversal Health Realty Income Trust	605.21M	43.62	34.35	-100%	11.84%	11.56%	8.11%
HCAHCA Healthcare, Inc.	118.45B	529.70	18.66	7.08%	8.97%		6.49%
THCTenet Healthcare Corporation	21.04B	239.39	15.45	3.12%	6.6%	15.68%	12.03%	1.47
AUNAAuna S.A.	160.71M	5.34	10.99	14.47%	4.33%	10.05%	100%	2.32
UHSUniversal Health Services, Inc.	2.58M	206.10	8.92	9.71%	8.57%	20.09%	100%	0.70
ARDTArdent Health Partners, LLC	1.34B	9.39	5.94	10.29%	3.24%	12.57%	9.51%	1.50
CYHCommunity Health Systems, Inc.	484.81M	3.46	0.92	-1.18%	4.08%		42.9%
ACHCAcadia Healthcare Company, Inc.	2.12B	23.44	-1.93	5.04%	-33.29%	-51.52%		1.23

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	18.44B	15.35B	14.15B	13.21B	11.79B	12.37B	12.21B	12.49B	12.63B	12.48B
Revenue Growth %	-5.14%	-16.73%	-7.8%	-6.68%	-10.76%	4.91%	-1.27%	2.28%	1.15%	-1.18%
Cost of Goods Sold+	11.63B	10.05B	8.74B	8.1B	7.37B	7.28B	7.3B	7.41B	7.36B	5.41B
COGS % of Revenue	63.1%	65.45%	61.74%	61.3%	62.55%	58.89%	59.82%	59.31%	58.29%	43.35%
Gross Profit+	6.8B	5.3B	5.42B	5.11B	4.42B	5.08B	4.91B	5.08B	5.27B	7.07B
Gross Margin %	36.9%	34.55%	38.26%	38.7%	37.45%	41.11%	40.18%	40.69%	41.71%	56.65%
Gross Profit Growth %	-8.04%	-22.02%	2.09%	-5.61%	-13.63%	15.15%	-3.5%	3.59%	3.7%	34.21%
Operating Expenses+	7.66B	7.18B	5.21B	4.46B	3.29B	3.68B	4.08B	4.13B	4.73B	11B
OpEx % of Revenue	41.56%	46.79%	36.79%	33.78%	27.9%	29.77%	33.45%	33.03%	37.42%	88.08%
Selling, General & Admin	450M	394M	337M	321M	327M	308M	317M	319M	299M	0
SG&A % of Revenue	2.44%	2.57%	2.38%	2.43%	2.77%	2.49%	2.6%	2.55%	2.37%	-
Research & Development	0	0	0	0	0	108M	85M	80M	0	0
R&D % of Revenue	-	-	-	-	-	0.87%	0.7%	0.64%	-	-
Other Operating Expenses	7.21B	6.79B	4.87B	4.14B	2.96B	3.27B	3.68B	3.73B	4.43B	11B
Operating Income+	-860M	-1.88B	208M	650M	1.13B	1.4B	821M	957M	542M	1.49B
Operating Margin %	-4.66%	-12.23%	1.47%	4.92%	9.55%	11.34%	6.72%	7.66%	4.29%	11.92%
Operating Income Growth %	-164.32%	-118.37%	111.08%	212.5%	73.23%	24.51%	-41.44%	16.57%	-43.36%	174.54%
EBITDA+	39M	-1.2B	768M	1.14B	1.56B	1.83B	1.27B	1.38B	948M	1.91B
EBITDA Margin %	0.21%	-7.78%	5.43%	8.61%	13.24%	14.83%	10.4%	11.06%	7.5%	15.33%
EBITDA Growth %	-98.3%	-3164.1%	164.27%	48.05%	37.29%	17.49%	-30.75%	8.82%	-31.4%	101.9%
D&A (Non-Cash Add-back)	899M	683M	560M	487M	435M	432M	449M	425M	406M	426M
EBIT	1.08B	216M	892M	902M	573M	1.28B	719M	870M	843M	0
Net Interest Income+	-962M	-931M	-976M	-1.04B	-1.03B	-885M	-858M	-830M	-860M	0
Interest Income	0	11M	0	0	0	0	0	2M	3M	0
Interest Expense	962M	942M	976M	1.04B	1.03B	885M	858M	832M	863M	870M
Other Income/Expense	-855M	-955M	-923M	0	-704M	-903M	-472M	-750M	-825M	-764M
Pretax Income+	-1.72B	-2.83B	-715M	-430M	422M	499M	349M	207M	-283M	724M
Pretax Margin %	-9.3%	-18.45%	-5.05%	-3.26%	3.58%	4.03%	2.86%	1.66%	-2.24%	5.8%
Income Tax+	-104M	-449M	-11M	160M	-185M	131M	170M	191M	79M	48M
Effective Tax Rate %	100.35%	86.8%	110.21%	137.21%	121.09%	46.09%	13.18%	-64.25%	182.33%	70.3%
Net Income+	-1.72B	-2.46B	-788M	-590M	511M	230M	46M	-133M	-516M	509M
Net Margin %	-9.33%	-16.02%	-5.57%	-4.47%	4.33%	1.86%	0.38%	-1.06%	-4.08%	4.08%
Net Income Growth %	-1189.24%	-42.88%	67.95%	25.13%	186.61%	-54.99%	-80%	-389.13%	-287.97%	198.64%
Net Income (Continuing)	-1.61B	-2.38B	-704M	-590M	607M	368M	179M	16M	-362M	509M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	667M	602M	576M	579M	571M	562M	633M	568M	597M	322M
EPS (Diluted)+	-15.54	-22.00	-6.99	-5.19	4.38	1.76	0.35	-1.02	-3.90	3.77
EPS Growth %	-1234.31%	-41.57%	68.23%	25.75%	184.39%	-59.82%	-80.11%	-391.43%	-282.35%	196.67%
EPS (Basic)	-15.55	-22.00	-6.99	-5.19	4.42	1.82	0.36	-1.02	-3.90	3.81
Diluted Shares Outstanding	110.73M	111.77M	112.73M	113.74M	116.54M	130.6M	130.06M	130.45M	132.1M	135M
Basic Shares Outstanding	110.71M	111.77M	112.73M	113.74M	115.49M	126.75M	128.81M	130.39M	132.1M	134M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	4.67B	4.07B	3.55B	3.43B	4.51B	3.48B	3.08B	3.21B	3.3B	3.23B
Cash & Short-Term Investments	238M	563M	196M	216M	1.68B	507M	118M	38M	37M	260M
Cash Only	238M	563M	196M	216M	1.68B	507M	118M	38M	37M	260M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	3.36B	2.54B	2.51B	2.4B	2.06B	2.18B	2.14B	2.36B	2.45B	2.08B
Days Sales Outstanding	66.55	60.31	64.65	66.18	63.87	64.22	63.88	69	70.69	60.72
Inventory	480M	444M	402M	354M	335M	355M	353M	328M	331M	0
Days Inventory Outstanding	15.06	16.13	16.79	15.96	16.58	17.79	17.64	16.16	16.41	-
Other Current Assets	382M	309M	245M	221M	202M	155M	138M	145M	197M	897M
Total Non-Current Assets+	17.28B	13.38B	12.31B	12.18B	11.5B	11.74B	11.59B	11.25B	10.75B	9.97B
Property, Plant & Equipment	8.15B	7.05B	6.14B	6.21B	5.96B	6.22B	6.1B	5.87B	5.4B	8.91B
Fixed Asset Turnover	2.26x	2.18x	2.31x	2.13x	1.98x	1.99x	2.00x	2.13x	2.34x	1.40x
Goodwill	6.52B	4.72B	4.56B	4.33B	4.22B	4.22B	4.17B	3.96B	3.79B	3.32B
Intangible Assets	674M	505M	423M	385M	305M	270M	224M	205M	172M	0
Long-Term Investments	177M	171M	269M	283M	190M	129M	155M	170M	152M	0
Other Non-Current Assets	1.76B	869M	851M	933M	759M	846M	890M	1.01B	1.23B	-2.31B
Total Assets+	21.94B	17.45B	15.86B	15.61B	16.01B	15.22B	14.67B	14.46B	14.05B	13.2B
Asset Turnover	0.84x	0.88x	0.89x	0.85x	0.74x	0.81x	0.83x	0.86x	0.90x	0.95x
Asset Growth %	-18.31%	-20.48%	-9.12%	-1.58%	2.54%	-4.93%	-3.6%	-1.46%	-2.77%	-6.05%
Total Current Liabilities+	2.89B	2.36B	2.39B	2.28B	2.81B	2.36B	2.19B	2.14B	2.35B	2.21B
Accounts Payable	880M	801M	772M	718M	683M	725M	686M	811M	784M	842M
Days Payables Outstanding	27.61	29.1	32.24	32.36	33.81	36.33	34.28	39.96	38.86	56.79
Short-Term Debt	455M	33M	204M	156M	265M	178M	169M	145M	135M	126M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	821M	837M	789M	814M	1.23B	806M	694M	615M	830M	2.08B
Current Ratio	1.62x	1.73x	1.48x	1.50x	1.60x	1.47x	1.41x	1.50x	1.41x	1.46x
Quick Ratio	1.45x	1.54x	1.32x	1.35x	1.48x	1.32x	1.25x	1.34x	1.27x	1.46x
Cash Conversion Cycle	54.01	47.35	49.19	49.77	46.65	45.68	47.24	45.2	48.24	-
Total Non-Current Liabilities+	16.77B	15.26B	14.43B	14.97B	14.24B	13.66B	13.22B	13.14B	13.03B	11.83B
Long-Term Debt	14.49B	13.59B	13.17B	13.12B	11.86B	11.72B	11.39B	11.25B	11.24B	537M
Capital Lease Obligations	302M	287M	218M	752M	756M	923M	825M	777M	728M	0
Deferred Tax Liabilities	411M	19M	26M	200M	29M	192M	354M	369M	231M	25M
Other Non-Current Liabilities	1.57B	1.36B	1.01B	894M	1.6B	827M	644M	739M	828M	11.27B
Total Liabilities	19.66B	17.61B	16.82B	17.25B	17.06B	16.03B	15.4B	15.28B	15.37B	14.04B
Total Debt+	15.24B	13.91B	13.6B	14.03B	12.88B	12.82B	12.39B	12.17B	12.1B	663M
Net Debt	15.01B	13.35B	13.4B	13.81B	11.21B	12.31B	12.27B	12.14B	12.06B	403M
Debt / Equity	6.68x	-	-	-	-	-	-	-	-	-
Debt / EBITDA	390.87x	-	17.70x	12.34x	8.25x	6.99x	9.75x	8.81x	12.77x	0.35x
Net Debt / EBITDA	384.77x	-	17.45x	12.15x	7.18x	6.71x	9.66x	8.78x	12.73x	0.21x
Interest Coverage	-0.89x	-1.99x	0.21x	0.62x	1.09x	1.58x	0.96x	1.15x	0.63x	1.71x
Total Equity+	2.28B	-165M	-959M	-1.64B	-1.05B	-810M	-734M	-824M	-1.32B	-515M
Equity Growth %	-51.2%	-107.23%	-481.21%	-70.91%	35.69%	23.15%	9.38%	-12.26%	-59.83%	60.9%
Book Value per Share	20.61	-1.48	-8.51	-14.41	-9.04	-6.20	-5.64	-6.32	-9.97	-3.81
Total Shareholders' Equity	1.61B	-767M	-1.53B	-2.22B	-1.63B	-1.37B	-1.37B	-1.39B	-1.91B	-837M
Common Stock	1M	1M	1M	1M	1M	1M	1M	1M	1M	1M
Retained Earnings	-299M	-2.76B	-3.54B	-4.22B	-3.71B	-3.48B	-3.43B	-3.56B	-4.08B	-3.57B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-62M	-21M	-10M	-9M	-13M	-14M	-21M	-14M	-10M	-9M
Minority Interest	667M	602M	576M	579M	571M	562M	633M	568M	597M	322M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	1.14B	773M	274M	385M	2.18B	-131M	300M	210M	480M	543M
Operating CF Margin %	6.17%	5.03%	1.94%	2.91%	18.47%	-1.06%	2.46%	1.68%	3.8%	4.35%
Operating CF Growth %	23.45%	-32.01%	-64.55%	40.51%	465.71%	-106.01%	329.01%	-30%	128.57%	13.13%
Net Income	-1.71B	-2.45B	-788M	-675M	511M	230M	46M	-133M	-516M	676M
Depreciation & Amortization	1.1B	861M	700M	608M	558M	540M	534M	505M	486M	426M
Stock-Based Compensation	0	0	0	0	0	0	0	0	0	11M
Deferred Taxes	-116M	-454M	-3M	203M	-187M	170M	165M	35M	-116M	-243M
Other Non-Cash Items	3.25B	2.29B	783M	520M	-29M	305M	34M	193M	635M	-327M
Working Capital Changes	-177M	525M	-418M	-271M	1.32B	-1.38B	-479M	-390M	-9M	0
Change in Receivables	-96M	732M	31M	93M	309M	-136M	22M	-193M	-66M	99M
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	0	-157M	-67M	16M	-158M	-50M	137M	0
Cash from Investing+	-608M	1.07B	-273M	-3M	191M	-543M	-251M	-22M	-277M	847M
Capital Expenditures	-867M	-570M	-527M	-438M	-440M	-469M	-415M	-467M	-360M	-335M
CapEx % of Revenue	4.7%	3.71%	3.72%	3.32%	3.73%	3.79%	3.4%	3.74%	2.85%	2.68%
Acquisitions	139M	1.7B	359M	593M	665M	5M	126M	426M	152M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	121M	0	0	1.2B
Cash from Financing+	-1.69B	-1.52B	-368M	-362M	-909M	-495M	-438M	-268M	-204M	-1.17B
Debt Issued (Net)	-1.86B	-1.52B	-1.07B	-322M	-794M	-369M	-305M	-123M	-48M	0
Equity Issued (Net)	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-6M	-5M	-1M	-1M	-1M	-5M	-8M	-4M	-1M	0
Other Financing	174M	5M	701M	-39M	-114M	-121M	-125M	-141M	-155M	-1.17B
Net Change in Cash	54M	325M	-367M	20M	1.46B	-1.17B	-389M	-80M	-1M	223M
Free Cash Flow+	1.49B	203M	-253M	-53M	1.74B	-600M	-115M	-257M	120M	208M
FCF Margin %	8.08%	1.32%	-1.79%	-0.4%	14.74%	-4.85%	-0.94%	-2.06%	0.95%	1.67%
FCF Growth %	1773.03%	-86.37%	-224.63%	79.05%	3379.25%	-134.52%	80.83%	-123.48%	146.69%	73.33%
FCF per Share	13.45	1.82	-2.24	-0.47	14.91	-4.59	-0.88	-1.97	0.91	1.54
FCF Conversion (FCF/Net Income)	-0.66x	-0.31x	-0.35x	-0.65x	4.26x	-0.57x	6.52x	-1.58x	-0.93x	1.07x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-49.47%	-232.31%	-	-	-	-	-	-	-	-
Return on Invested Capital (ROIC)	-3.32%	-9.24%	1.22%	3.96%	7.57%	9.71%	5.34%	6.28%	3.69%	20.99%
Gross Margin	36.9%	34.55%	38.26%	38.7%	37.45%	41.11%	40.18%	40.69%	41.71%	56.65%
Net Margin	-9.33%	-16.02%	-5.57%	-4.47%	4.33%	1.86%	0.38%	-1.06%	-4.08%	4.08%
Debt / Equity	6.68x	-	-	-	-	-	-	-	-	-
Interest Coverage	-0.89x	-1.99x	0.21x	0.62x	1.09x	1.58x	0.96x	1.15x	0.63x	1.71x
FCF Conversion	-0.66x	-0.31x	-0.35x	-0.65x	4.26x	-0.57x	6.52x	-1.58x	-0.93x	1.07x
Revenue Growth	-5.14%	-16.73%	-7.8%	-6.68%	-10.76%	4.91%	-1.27%	2.28%	1.15%	-1.18%

Community Health Systems, Inc. (CYH) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare CYH vs Peers

vs HCA

vs THC

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Community Health Systems, Inc. (CYH) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare CYH vs Peers

vs HCA

vs THC

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios